Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.
Saved in:
| Title: | Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605. |
|---|---|
| Authors: | Kotýnková K; Broad Institute Cambridge, MA United States., Andersen S; Broad Institute Cambridge, MA United States., Denney D; Broad Institute Cambridge, MA United States., Karsli Uzunbas G; Broad Institute Cambridge, MA United States., Burri M; Broad Institute Cambridge, MA United States., Wu X; Broad Institute Cambridge, MA United States., Kaplan B; Broad Institute Cambridge, MA United States., Haq R; Dana-Farber Cancer Institute Boston, MA United States., Meyerson M; Dana-Farber Cancer Institute Boston, MA United States., Greulich H; Broad Institute Cambridge, MA United States. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1538-8514 |
|---|---|
| DOI: | 10.1158/1535-7163.MCT-25-1473 |
